Literature DB >> 25179232

Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs.

Joanne L Fothergill1, Daniel R Neill1, Nick Loman2, Craig Winstanley1, Aras Kadioglu1.   

Abstract

Chronic bacterial infections are a key feature of a variety of lung conditions. The opportunistic bacterium, Pseudomonas aeruginosa, is extremely skilled at both colonizing and persisting in the airways of patients with lung damage. It has been suggested that the upper airways (including the paranasal sinuses and nasopharynx) play an important role as a silent reservoir of bacteria. Over time, P. aeruginosa can adapt to its niche, leading to increased resistance in the face of the immune system and intense therapy regimes. Here we describe a mouse inhalation model of P. aeruginosa chronic infection that can be studied for at least 28 days. We present evidence for adaptation in vivo, in terms of genotype and phenotype including antibiotic resistance. Our data suggest that there is persistence in the upper respiratory tract and that this is key in the establishment of lung infection. This model provides a unique platform for studying evolutionary dynamics and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25179232     DOI: 10.1038/ncomms5780

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  33 in total

1.  Adaptation... that's what you need?

Authors:  Chrispin Chaguza; Stephen D Bentley
Journal:  Nat Rev Microbiol       Date:  2017-07-10       Impact factor: 60.633

Review 2.  Experimental Design, Population Dynamics, and Diversity in Microbial Experimental Evolution.

Authors:  Bram Van den Bergh; Toon Swings; Maarten Fauvart; Jan Michiels
Journal:  Microbiol Mol Biol Rev       Date:  2018-07-25       Impact factor: 11.056

Review 3.  Phage therapy for respiratory infections.

Authors:  Rachel Yoon Kyung Chang; Martin Wallin; Yu Lin; Sharon Sui Yee Leung; Hui Wang; Sandra Morales; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2018-08-07       Impact factor: 15.470

Review 4.  Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Authors:  Maria Magana; Christina Sereti; Anastasios Ioannidis; Courtney A Mitchell; Anthony R Ball; Emmanouil Magiorkinis; Stylianos Chatzipanagiotou; Michael R Hamblin; Maria Hadjifrangiskou; George P Tegos
Journal:  Clin Microbiol Rev       Date:  2018-04-04       Impact factor: 26.132

Review 5.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

6.  Diversity of Mycobacterium tuberculosis across Evolutionary Scales.

Authors:  Mary B O'Neill; Tatum D Mortimer; Caitlin S Pepperell
Journal:  PLoS Pathog       Date:  2015-11-12       Impact factor: 6.823

Review 7.  Contact lens-related corneal infection: Intrinsic resistance and its compromise.

Authors:  Suzanne M J Fleiszig; Abby R Kroken; Vincent Nieto; Melinda R Grosser; Stephanie J Wan; Matteo M E Metruccio; David J Evans
Journal:  Prog Retin Eye Res       Date:  2019-11-20       Impact factor: 21.198

8.  Loss of a pyoverdine secondary receptor in Pseudomonas aeruginosa results in a fitter strain suitable for population invasion.

Authors:  Jaime González; Manuel Salvador; Özhan Özkaya; Matt Spick; Kate Reid; Catia Costa; Melanie J Bailey; Claudio Avignone Rossa; Rolf Kümmerli; José I Jiménez
Journal:  ISME J       Date:  2020-12-15       Impact factor: 10.302

9.  Rampant prophage movement among transient competitors drives rapid adaptation during infection.

Authors:  Christopher W Marshall; Erin S Gloag; Christina Lim; Daniel J Wozniak; Vaughn S Cooper
Journal:  Sci Adv       Date:  2021-07-16       Impact factor: 14.136

10.  NtrBC Selectively Regulates Host-Pathogen Interactions, Virulence, and Ciprofloxacin Susceptibility of Pseudomonas aeruginosa.

Authors:  Morgan A Alford; Beverlie Baquir; Andy An; Ka-Yee G Choi; Robert E W Hancock
Journal:  Front Cell Infect Microbiol       Date:  2021-06-24       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.